论文部分内容阅读
目的:总结布加综合征(BCS)合并肝脏结节的诊治经验。方法:回顾性分析2012年1月至2018年12月于河南省人民医院治疗的BCS合并肝脏结节患者临床资料。共入组患者33例，其中男性17例，女性16例，平均年龄51岁。分析不同性质结节的治疗和预后。结果:33例BCS患者合并肝脏结节，27例为肝细胞癌，6例为良性增生性结节。27例合并肝细胞癌患者中1例行介入栓塞化疗，26例行肝细胞癌切除手术，整体生存时间10.0～78.0个月，平均37.8个月。该类型良性结节均为多发，诊断后临床随访期间未见恶变。结论:BCS合并的良性结节，无需特殊处理，但应与肝细胞癌鉴别。BCS合并的肝细胞癌预后较好，应在解除肝脏流出道梗阻的同时积极手术切除。“,”Objective:To summarize our experience in diagnosis and treatment of Budd-Chiari syndrome(BCS) accompanied with hepatic nodules.Methods:The clinical data of 33 patients with BCS accompanied with hepatic nodules who were treated at Henan Provincial People's Hospital from January 2012 to December 2018 were retrospectively analysed. A total of 33 patients were enrolled, including 17 males and 16 females, with an average age of 51 years. Analyze the treatment and prognosis of different types of nodules.Results:Of 33 patients, 27 were diagnosed to have hepatocellular carcinoma and 6 benign proliferative nodules. Treatment of patients with hepatocellular carcinoma included, transcatheter arterial chemoembolization (n n=1) and hepatectomy (n n=26). The survival time of these patients with hepatocellular carcinoma ranged from 10.0 to 78.0 months (mean 37.8 months). For the remaining 6 patients with benign nodules, the nodules were multiple and no malignant changes were observed on follow-up.n Conclusion:For patients with BCS associated with benign nodules, no specific treatment was required. Hepatocellular carcinoma assocated with BCS had good prognosis. An aggressive surgical resectional approach is recommended to treat and to relieve the hepatic outflow obstruction.